ArticleTheranostics2022

AKR1C3-dependent lipid droplet formation confers hepatocellular carcinoma cell adaptability to targeted therapy.

Changqing Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.